Xu, Ai-E <br/><br/>
Efficacy and safety of tarcrolimus cream 0.1% in the treatment of vitiligo.  [electronic resource] 

 -  International journal of dermatology  Jan 2009 
 - 86-90 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1365-4632 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-4632.2009.03852.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Topical<br/>Adolescent<br/>Adult<br/>Analysis of Variance<br/>Child<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Drug-Related Side Effects and Adverse Reactions<br/>Emollients<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Immunosuppressive Agents--adverse effects<br/>Male<br/>Pilot Projects<br/>Prospective Studies<br/>Severity of Illness Index<br/>Tacrolimus--adverse effects<br/>Treatment Outcome<br/>Vitiligo--diagnosis<br/>Young Adult